Grb2-SH2 ligands (Novartis)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGrb2-SH2 ligands (Novartis)
Drug Alias NameSH2 domain inhibitors (Novartis)CGP-78850
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionGrowth factor receptor-bound protein 2 inhibitors
TargetsGrowth factor receptor-bound protein 2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A